Journal of clinical epidemiology
-
Comparing observed and expected distributions of baseline variables in randomized controlled trials (RCTs) has been used to investigate possible research misconduct, although the validity of this approach has been questioned. We explored this technique and introduced a novel metric to compare P values from baseline variables between treatment arms. ⋯ Assessing baseline P values in groups of RCTs can identify highly unusual distributions that might raise or reinforce concerns about randomization and data integrity.
-
The Core Outcome Set-STAndards for Development (COS-STAD) contains 11 standards (12 criteria) that are deemed to be the minimum design recommendations for all core outcome set (COS) development projects. Cancer is currently the disease area with the highest number of published COSs and is a major cause of worldwide morbidity and mortality. The aim of this study was to provide a baseline of cancer COS standards. ⋯ With the exception of "scope" specification, there is much need for improvement. Poor reporting often made it challenging to assess whether minimum standards were met. The consensus process criteria were most difficult to assess, particularly those that required an assessment of being a priori. This is the first application of COS-STAD criteria to studies that have developed COSs and provides a baseline of cancer COS standards of development.